Compounds > atazanavir sulfate
Page last updated: 2024-09-04

atazanavir sulfate and oxybutynin

atazanavir sulfate has been researched along with oxybutynin in 1 studies

Compound Research Comparison

Studies
(atazanavir sulfate)		Trials
(atazanavir sulfate)		Recent Studies (post-2010)
(atazanavir sulfate)		Studies
(oxybutynin)		Trials
(oxybutynin)		Recent Studies (post-2010) (oxybutynin)
1,1022465902,6076191,670

Protein Interaction Comparison

ProteinTaxonomyatazanavir sulfate (IC50)oxybutynin (IC50)
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)2.5951
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.027
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.002
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.0032
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.0035
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.0027
Sodium-dependent noradrenaline transporter Homo sapiens (human)2.5951
Cytochrome P450 2C19Homo sapiens (human)0.6
D(3) dopamine receptorHomo sapiens (human)0.4288
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.792
Sodium-dependent dopamine transporter Homo sapiens (human)0.0855
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.0242

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies

Other Studies

1 other study(ies) available for atazanavir sulfate and oxybutynin

ArticleYear
Recent changes to FDA-approved labeling.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2004, Sep-01, Volume: 61, Issue:17

    Topics: Acetamides; Aminoquinolines; Atazanavir Sulfate; Atorvastatin; Botulinum Toxins, Type A; Dosage Forms; Drug Labeling; Epoetin Alfa; Erythropoietin; Heptanoic Acids; Humans; Imiquimod; Insulin; Insulin Lispro; Mandelic Acids; Oligopeptides; Oseltamivir; Pyridines; Pyrroles; Recombinant Proteins; United States; United States Food and Drug Administration

2004